Hematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousHematopoietic Stem CellsStem Cell TransplantationTransplantation ConditioningGraft vs Host DiseaseBone Marrow TransplantationPeripheral Blood Stem Cell TransplantationHematologic NeoplasmsStem CellsLiver TransplantationTreatment OutcomeGraft SurvivalTransplantation ChimeraHematopoietic Stem Cell MobilizationTissue DonorsMultiple MyelomaWhole-Body IrradiationAntigens, CD34BusulfanCord Blood Stem Cell TransplantationMyeloablative AgonistsHematopoiesisRecurrenceKidney TransplantationRetrospective StudiesHistocompatibility TestingCombined Modality TherapyMelphalanCell TransplantationHistocompatibilityRemission InductionLeukemiaImmunosuppressive AgentsChimerismGraft vs Leukemia EffectSalvage TherapyDisease-Free SurvivalBone Marrow CellsSurvival RateCell DifferentiationSurvival AnalysisCyclophosphamideTime FactorsGranulocyte Colony-Stimulating FactorMesenchymal Stem Cell TransplantationGraft vs Tumor EffectTransplantation ImmunologyLymphoma, Non-HodgkinLeukemia, Myeloid, AcuteHeart TransplantationMyelodysplastic SyndromesAntineoplastic Combined Chemotherapy ProtocolsBone MarrowHLA AntigensHematologic DiseasesLung TransplantationHepatic Veno-Occlusive DiseaseFlow CytometryTransplantation, IsogeneicGraft RejectionSiblingsVidarabineUnrelated DonorsCell LineageFollow-Up StudiesOrgan TransplantationColony-Forming Units AssayEmbryonic Stem CellsStem Cell NicheMice, Inbred C57BLAdult Stem CellsTransplantationLymphocyte TransfusionLeukapheresisCells, CulturedSevere Combined ImmunodeficiencyCell SeparationCytarabineHodgkin DiseaseBone Marrow PurgingFetal BloodCarmustineEtoposidePrecursor Cell Lymphoblastic Leukemia-LymphomaPrognosisCytomegalovirus InfectionsAntilymphocyte SerumDonor SelectionT-LymphocytesImmunosuppressionAnemia, AplasticLeukemia, Myelogenous, Chronic, BCR-ABL PositiveAcute DiseaseLymphocyte DepletionNeoplasm, ResidualIslets of Langerhans TransplantationLiving DonorsAllografts